TherapeuticsMD Inc expected to post a loss of 10 cents a share - Earnings Preview

TherapeuticsMD

09/11/2021 18:57

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show a
rise in quarterly revenue when it reports  results on November
11. 
* The Boca Raton, Florida-based company is expected to report  a
33.8% increase in revenue to $25.872 million from $19.34 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for TherapeuticsMD Inc is
for a loss of 10 cents per share. For the same quarter last
year, the company reported a loss of 12 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5​, about 85.1% above​ its last closing price
of $0.75. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.11       -0.11      -0.11     Met     0
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    5.2
 Dec. 31 2020  -0.11       -0.10      -0.15     Missed  -42.9​
 Sep. 30 2020  -0.14       -0.14      -0.12     Beat    12.2
 ​​Jun.        -0.17       -0.17      -0.19     Missed  -10.7
 30 2020                                                
 Mar. 31 2020  -0.19       -0.19      -0.21     Missed  -12​
 Dec. 31 2019  -0.19       -0.19      -0.19     Met     -1.5
 Sep. 30 2019  -0.19       -0.19      -0.13     Beat    32.2
 This summary was machine generated November 9 at 18:57 GMT.  All
figures in US dollars  unless otherwise stated